Kaiser Permanente conducts innovative, translational research that is an integral part of our social mission and essential to providing members with quality health care.
September 17, 2020
A new study led by Permanente physician-researchers found young people felt more comfortable talking about gender identity issues when asked first by a clinician.
August 25, 2020
Kaiser Permanente researchers to study Vascepa in people 50 and older with heart disease.
August 13, 2020
The late-stage clinical trial will test the vaccine in 1,400 adults at 4 sites in California and Oregon.
July 22, 2020
Kaiser Permanente study published in the journal Gastroenterology supports starting screening at age 45 among this higher-risk population.